Received Nov 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Very fatigue; in additional to the pain at night; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fatigue in a patient who received Herpes zoster (Herpes Zoster vaccine) for prophylaxis. On an unknown date, the patient received Herpes Zoster vaccine. On an unknown date, an unknown time after receiving Herpes Zoster vaccine, the patient experienced fatigue (Verbatim: Very fatigue) and pain (Verbatim: in additional to the pain at night). The outcome of the fatigue and pain were not reported. It was unknown if the reporter considered the fatigue and pain to be related to Herpes Zoster vaccine. It was unknown if the company considered the fatigue and pain to be related to Herpes Zoster vaccine. Additional Information: GSK Receipt Date: 08-NOV-2025 This case was reported by a patient via (Open field AE monitoring) interactive digital media. The batch number was not provided, and unable to contact the reporter.